In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity.
BACKGROUND
Water-soluble fullerenes have recently been shown to exhibit considerable in vitro biological activity including cytotoxicity, site-selective DNA cleavage and inhibition of HIV protease. To assess the potential of these compounds as drugs, studies on the in vivo behavior of fullerenes are needed. We therefore set out to synthesize a radiolabeled, water-soluble fullerene, in order to obtain data on the oral absorption, distribution and excretion of this class of compounds.


RESULTS
We synthesized a 14C-labeled water-soluble [60]fullerene using dipolar trimethylenemethane, which undergoes cycloaddition to [60]fullerene. When administered orally to rats, this compound was not efficiently absorbed and was excreted primarily in the feces. When injected intravenously, however, it was distributed rapidly to various tissues, and most of the material was retained in the body after one week. The compound was also able to penetrate the blood-brain barrier. Acute toxicity of the water-miscible fullerene was found to be quite low.


CONCLUSIONS
Although the water-soluble fullerenes (and possibly their simple metabolites) are not acutely toxic, they are retained in the body for long periods, raising concerns about chronic toxic effects. The fact that fullerenes distribute rapidly to many tissues suggests that they may eventually be useful to deliver highly polar drugs through membranes to a target tissue, however, and they may even have applications in the delivery of drugs to the brain. Recent advances in fullerene synthetic chemistry may also make it possible to control fullerene absorption/excretion profiles in the future.
Yamago
S
S
Department of Chemistry, Tokyo Institute of Technology, Japan.
Tokuyama
H
H
Nakamura
E
E
Kikuchi
K
K
Kananishi
S
S
Sueki
K
K
Nakahara
H
H
Enomoto
S
S
Ambe
F
F
D000284:Administration, Oral; D000818:Animals; D001812:Blood-Brain Barrier; D002244:Carbon / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000633:toxicity; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D005243:Feces / Q000737:chemistry; D005260:Female; D037741:Fullerenes; D007202:Indicators and Reagents; D007275:Injections, Intravenous; D007553:Isotope Labeling; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D051381:Rats; D011916:Rats, Inbred F344; D012995:Solubility; D014018:Tissue Distribution; D014867:Water
D037741:Fullerenes; D007202:Indicators and Reagents; D014867:Water; D002244:Carbon; C069837:fullerene C60